首页> 美国卫生研究院文献>Blood >The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations
【2h】

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

机译:急性髓细胞白血病的隐藏基因组景观:未检测到的突变揭示了亚克隆结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The analyses carried out using 2 different bioinformatics pipelines (SomaticSniper and MuTect) on the same set of genomic data from 133 acute myeloid leukemia (AML) patients, sequenced inside the Cancer Genome Atlas project, gave discrepant results. We subsequently tested these 2 variant-calling pipelines on 20 leukemia samples from our series (19 primary AMLs and 1 secondary AML). By validating many of the predicted somatic variants (variant allele frequencies ranging from 100% to 5%), we observed significantly different calling efficiencies. In particular, despite relatively high specificity, sensitivity was poor in both pipelines resulting in a high rate of false negatives. Our findings raise the possibility that landscapes of AML genomes might be more complex than previously reported and characterized by the presence of hundreds of genes mutated at low variant allele frequency, suggesting that the application of genome sequencing to the clinic requires a careful and critical evaluation. We think that improvements in technology and workflow standardization, through the generation of clear experimental and bioinformatics guidelines, are fundamental to translate the use of next-generation sequencing from research to the clinic and to transform genomic information into better diagnosis and outcomes for the patient.
机译:使用2条不同的生物信息学管道(SomaticSniper和MuTect)对来自133个急性髓样白血病(AML)患者的同一组基因组数据进行了分析,并在Cancer Genome Atlas项目中进行了排序,得出了不一致的结果。随后,我们在我们系列的20个白血病样本(19个原发性AML和1个继发性AML)中测试了这2条变异检测途径。通过验证许多预测的体细胞变异(变异等位基因频率范围从100%到5%),我们观察到了明显不同的呼叫效率。特别是,尽管特异性相对较高,但两条管道的灵敏度均很低,导致假阴性率很高。我们的发现增加了AML基因组的格局可能比以前报道的更为复杂的可能性,并且其特征是存在以低等位基因频率突变的数百个基因,这表明将基因组测序应用于临床需要进行认真而严格的评估。我们认为,通过生成清晰的实验和生物信息学指南,技术和工作流程标准化的改进对于将下一代测序的使用从研究转化为临床以及将基因组信息转化为更好的患者诊断和疗效至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号